Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population
Titel:
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population
Auteur:
Fagerberg, B. Edwards, S. Halmos, T. Lopatynski, J. Schuster, H. Stender, S. Stoa-Birketvedt, G. Tonstad, S. Halldórsdóttir, S Gause-Nilsson, I.